Clinical Trial: A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07708493) titled 'A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight' on July 13.

Brief Summary: The main objectives of this trial are:

To assess the mass balance (total recovery of [14C]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.

Study Start Date: July 29

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: BI 3034701 (C-14)

BI 3034701 mixed with [C-14]BI 3034701

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Published by HT Digital Content Serv...